We observed that CA-Cdc42 expression does not increase cell proliferation, suggesting that the significant increase in glioma migration with doxycycline induction is not accompanied by changes in proliferation status (Supplementary Figure S1). The gene discussed is CDC42; the disease is central nervous system cancer.